Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · IEX Real-Time Price · USD
1.150
-0.010 (-0.86%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Assertio Holdings Revenue

Assertio Holdings had revenue of $142.05M in the twelve months ending March 31, 2024, down -12.40% year-over-year. Revenue in the quarter ending March 31, 2024 was $32.45M, a -23.59% decrease year-over-year. In the year 2023, Assertio Holdings had annual revenue of $152.07M, a decrease of -2.67%.

Revenue (ttm)
$142.05M
Revenue Growth
-12.40%
P/S Ratio
0.77
Revenue / Employee
$2,680,208
Employees
53
Market Cap
109.39M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023152.07M-4.17M-2.67%
Dec 31, 2022156.23M45.22M40.73%
Dec 31, 2021111.01M4.74M4.46%
Dec 31, 2020106.28M-123.23M-53.69%
Dec 31, 2019229.50M-82.27M-26.39%
Dec 31, 2018311.77M-68.95M-18.11%
Dec 31, 2017380.72M-75.17M-16.49%
Dec 31, 2016455.90M113.16M33.02%
Dec 31, 2015342.74M-47.63M-12.20%
Dec 31, 2014390.36M256.16M190.87%
Dec 31, 2013134.21M43.39M47.78%
Dec 31, 201290.82M-42.16M-31.70%
Dec 31, 2011132.97M52.21M64.64%
Dec 31, 201080.76M23.04M39.90%
Dec 31, 200957.73M22.89M65.69%
Dec 31, 200834.84M-30.74M-46.87%
Dec 31, 200765.58M56.03M586.65%
Dec 31, 20069.55M5.15M116.82%
Dec 31, 20054.41M4.20M2,074.57%
Dec 31, 2004202.57K-779.42K-79.37%
Dec 31, 2003981.99K-679.20K-40.89%
Dec 31, 20021.66M-2.01M-54.78%
Dec 31, 20013.67M1.90M106.81%
Dec 31, 20001.78M1.66M1,440.16%
Dec 31, 1999115.33K-647.81K-84.89%
Dec 31, 1998763.14K158.26K26.16%
Dec 31, 1997604.88K286.91K90.23%
Dec 31, 1996317.97K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Well 254.57M
FibroGen 167.49M
Akoya Biosciences 93.57M
Seer, Inc. 15.67M
Veru Inc. 13.48M
Revenue Rankings